181 posters,  2 sessions,  10 topics,  159 authors,  140 institutions

ePostersLive® by SciGen® Technologies S.A. All rights reserved.

P5
Staged thoracic endovascular aortic repair of extensive aortic arch aneurysm

Primary tabs

Poster Presenter
Affiliations

Rate

No votes yet

Statistics

726 reads

Staged thoracic endovascular aortic repair for extensive aortic arch aneurysm

 

Akihiro yoshitake, Kazuma Okamoto, Mikihiko Kudo, Ryo Aeba, Ichiro Kashima, Mio Kasai, Akinori Hirano, Yuuta Akamatsu, Takayuki Kawashima, Hiroto Kitahara, Hideyuki Shimizu

 

Department of Cardiovascular surgery

Keio University, Tokyo, Japan

 

Background

Extensive aortic arch aneurysms (ascending aorta, aortic arch, and descending aorta) require innovative surgical techniques. We adopted two -staged procedure, open total arch replacement with elephant trunk as a first stage and thoracic endovascular aortic repair (TEVAR) as second stage, for elective repair of extensive aortic arch aneurysms. The objective is to evaluate the perioperative and mid-term results of staged TEVAR to extensive aortic arch aneurysms.

Methods

Between January 2009 and April 2016, we planed staged TEVAR in 44 patients with a mean age of 72.8. Of these, all the patients were treated with total arch replacement with elephant trunk procedures as first stage. Second stage (TEVAR) was completed in 42 of 42 (95.5%) patients. Median duration between two stages was 2.2 months (range: 0-22 months).

Results

There was no hospital mortality at first stage and second stage. Mortality rate during the interval between first stage and second stage was 4.5%(2 of 44), of which one patient died on 2 months after first stage and the other on 11 months after first stage operation due to aneurysm rupture. One of 44 (2.2%) first stage patients had stroke. No stroke occurred in second stage. No spinal cord dysfunction occurred both in first and second stages.  The cumulative survival rate was 97% and 85.5% at 1 and 3 years, respectively. Freedom from arotic related reoperation rate was 97.2% and 94.3% at 1 and 3 years, respectively.

Conclusions

Extensive aortic aneurysms can be treated with acceptable morbidity and mortality rates through the use of staged TEVAR. After staged TEVAR was performed, patients have acceptable mid term survival.

Enter Poster ID (e.gGoNextPreviousCurrent